• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GM1和GM2神经节苷脂沉积症的神经生理学研究

Neurophysiological investigations in GM1 and GM2 gangliosidoses.

作者信息

Pampiglione G, Harden A

出版信息

Neuropediatrics. 1984 Sep;15 Suppl:74-84. doi: 10.1055/s-2008-1052386.

DOI:10.1055/s-2008-1052386
PMID:6100798
Abstract

Neurophysiological studies (EEG, ERG, VEP and BAEP) have been carried out on a total of fifty-four patients (fourty-five GM2 and nine GM1 gangliosidosis) at various stages of the disease process. In infantile GM2 gangliosidosis, the EEG was midly abnormal from an early age but by the age of one year there was a rapid and progressive deterioration. EEG changes in late onset GM2 gangliosidosis were very variable and unrelated to age or enzyme defect. In both Type 1 and Type 2 GM1 gangliosidosis there was a progressive deterioration of the EEG. Paroxysmal features were not prominent in any of the gangliosidoses, despite the occurrence of seizures. The ERG remained normal in both GM2 and GM1 patients. In the infantile GM2 patients there was progressive loss of the VEP between nine and fifteen months of age but the timing of VEP changes were more variable in all the other groups. Evidence of brainstem dysfunction was found in one of the two TSD patients tested. The combined neurophysiological features appear to be characteristic for each group of gangliosidosis and differ from other neurometabolic disorders of childhood.

摘要

我们对54例处于疾病不同阶段的患者(45例GM2神经节苷脂沉积症和9例GM1神经节苷脂沉积症)进行了神经生理学研究(脑电图、视网膜电图、视觉诱发电位和脑干听觉诱发电位)。在婴儿型GM2神经节苷脂沉积症中,脑电图从早期就有轻度异常,但到1岁时会迅速且进行性恶化。晚发型GM2神经节苷脂沉积症的脑电图变化差异很大,与年龄或酶缺陷无关。在1型和2型GM1神经节苷脂沉积症中,脑电图均呈进行性恶化。尽管有癫痫发作,但在任何一种神经节苷脂沉积症中,阵发性特征都不突出。GM2和GM1患者的视网膜电图均保持正常。在婴儿型GM2患者中,9至15个月大时视觉诱发电位逐渐丧失,但在所有其他组中,视觉诱发电位变化的时间更具变异性。在接受测试的2例泰-萨氏病患者中,有1例发现脑干功能障碍的证据。综合神经生理学特征似乎是每组神经节苷脂沉积症所特有的,与儿童期其他神经代谢疾病不同。

相似文献

1
Neurophysiological investigations in GM1 and GM2 gangliosidoses.GM1和GM2神经节苷脂沉积症的神经生理学研究
Neuropediatrics. 1984 Sep;15 Suppl:74-84. doi: 10.1055/s-2008-1052386.
2
Morphology of the gangliosidoses.神经节苷脂贮积症的形态学
Neuropediatrics. 1984 Sep;15 Suppl:97-106. doi: 10.1055/s-2008-1052389.
3
Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.培养成纤维细胞的神经节苷脂负载:一种用于诊断GM2神经节苷脂沉积症的激发方法。
Clin Chim Acta. 1986 Apr 15;156(1):41-9. doi: 10.1016/0009-8981(86)90177-4.
4
High-resolution loading tests in the study of genetic heterogeneity in gangliosidosis fibroblasts.神经节苷脂贮积症成纤维细胞遗传异质性研究中的高分辨率负荷试验
J Inherit Metab Dis. 1994;17(1):104-11. doi: 10.1007/BF00735405.
5
The biochemical basis of gangliosidoses.神经节苷脂贮积症的生化基础。
Neuropediatrics. 1984 Sep;15 Suppl:85-92. doi: 10.1055/s-2008-1052387.
6
[GM2 gangliosidosis].
Ryoikibetsu Shokogun Shirizu. 1999(27 Pt 2):177-9.
7
Neurophysiological studies in GM1, gangliosidosis.GM1神经节苷脂贮积症的神经生理学研究。
Ital J Neurol Sci. 1982 Oct;3(3):201-6. doi: 10.1007/BF02043310.
8
Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.婴儿型和青少年型神经节苷脂贮积症的脑部疾病进展模式不同:容积定量 MRI 研究。
Mol Genet Metab. 2018 Feb;123(2):97-104. doi: 10.1016/j.ymgme.2017.12.432. Epub 2017 Dec 20.
9
Plasma G ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-Gangliosidosis.血浆 G 神经节苷脂可能成为 GM2 神经节苷脂贮积症的诊断、预后和疾病监测的生物标志物。
Mol Genet Metab. 2023 Feb;138(2):106983. doi: 10.1016/j.ymgme.2022.106983. Epub 2022 Dec 26.
10
Synopsis: gangliosidoses.概要:神经节苷脂贮积症
Neuropediatrics. 1984 Sep;15 Suppl:107-9. doi: 10.1055/s-2008-1052390.

引用本文的文献

1
GM1 and GM2-Gangliosidosis: Clinical Features, Neuroimaging Findings and Electroencephalography.GM1和GM2神经节苷脂贮积症:临床特征、神经影像学表现及脑电图
Iran J Child Neurol. 2024 Spring;18(2):127-140. doi: 10.22037/ijcn.v18i2.40751. Epub 2024 Mar 12.
2
A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis.用于监测 GM1 神经节苷脂贮积症基因治疗药效反应的五糖
EBioMedicine. 2023 Jun;92:104627. doi: 10.1016/j.ebiom.2023.104627. Epub 2023 May 31.
3
Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model.
人类GM1神经节苷脂贮积症的新型生物标志物反映了猫模型中基因治疗的临床疗效。
Mol Ther. 2017 Apr 5;25(4):892-903. doi: 10.1016/j.ymthe.2017.01.009. Epub 2017 Feb 22.
4
Biomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff disease.猫桑德霍夫病疾病进展和腺相关病毒治疗效果的生物标志物
Exp Neurol. 2015 Jan;263:102-12. doi: 10.1016/j.expneurol.2014.09.020. Epub 2014 Oct 5.
5
The electroretinogram.视网膜电图
Arch Dis Child. 1989 Jul;64(7):1080-7. doi: 10.1136/adc.64.7.1080.